{
    "2021-02-03": [
        [
            {
                "time": "2021-02-03",
                "original_text": "心通医疗-B公开发售获认购超769倍 每股发售价12.2港元",
                "features": {
                    "keywords": [
                        "心通医疗-B",
                        "公开发售",
                        "认购",
                        "769倍",
                        "12.2港元"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-02-03",
                "original_text": "多家上市药企报喜拟中标药品集采，集采常态化医药板块如何走？",
                "features": {
                    "keywords": [
                        "上市药企",
                        "药品集采",
                        "集采常态化",
                        "医药板块"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "mixed"
                }
            },
            {
                "time": "2021-02-03",
                "original_text": "最高降幅95%！第四批药品带量采购竞标新出炉",
                "features": {
                    "keywords": [
                        "药品带量采购",
                        "最高降幅",
                        "95%",
                        "第四批"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-02-03",
                "original_text": "复星医药(02196)完成发行16亿元公司债 票面利率为3.98%",
                "features": {
                    "keywords": [
                        "复星医药",
                        "公司债",
                        "16亿元",
                        "票面利率",
                        "3.98%"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-02-03",
                "original_text": "三大指数弱势震荡沪指跌0.46%，科技股大幅跳水，北向资金净买入34亿",
                "features": {
                    "keywords": [
                        "三大指数",
                        "弱势震荡",
                        "沪指",
                        "科技股",
                        "北向资金",
                        "净买入",
                        "34亿"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "科技"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-02-03",
                "original_text": "第四轮国家药品集采：复星医药子公司中标索拉非尼",
                "features": {
                    "keywords": [
                        "国家药品集采",
                        "复星医药",
                        "子公司",
                        "中标",
                        "索拉非尼"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-02-03",
                "original_text": "第四批集采结果将在5月执行 机构看好这些药企",
                "features": {
                    "keywords": [
                        "第四批集采",
                        "5月执行",
                        "机构看好",
                        "药企"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}